Xeris Biopharma Holdings (XERS) Asset Utilization Ratio (2021 - 2026)

Xeris Biopharma Holdings has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.81 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 16.48% year-over-year to 0.81; the trailing twelve-month figure through Mar 2026 stood at 0.81 (up 16.48% YoY), and the FY2025 full-year result was 0.83, up 31.32% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.81, up from 0.77 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.81 in Q1 2026, with the low at 0.2 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.52 across 5 years, with a median of 0.52 in 2024.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio surged 84.37% — and 2026, when it rose 16.48%.
• Xeris Biopharma Holdings' Asset Utilization Ratio stood at 0.34 in 2022, then surged by 48.03% to 0.5 in 2023, then grew by 25.08% to 0.63 in 2024, then gained by 22.83% to 0.77 in 2025, then rose by 4.85% to 0.81 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.81 (Q1 2026), 0.77 (Q4 2025), and 0.76 (Q3 2025), per Business Quant data.